InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Rubin Jonathan. Officer active across 1 company, notably Supernus Pharmaceuticals, INC.. Cumulatively, 13 reports have been logged. History available since 16 February 2023. The latest transaction was filed on 12 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
Rubin Jonathan is a declarant linked to Supernus Pharmaceuticals, INC. (XNAS), where he holds the role of SVP, Chief Medical Officer. He has 11 filings in total, and across the 11 sampled filings the most frequent transaction nature is Attribution, with buy and sell amounts at EUR 0; the sampled period runs from 2023-02-21 to 2026-02-26.